Optimize immunotherapy with Creative Biolabs' TCR-T and CAR-T/NK exhaustion assays.
Creative Biolabs provides services that include the most advanced TME-mimicking assays to assess the exhaustion status of immune cells, such as cytokine production, expression of inhibitory markers and immune cell degranulation. We offer multiple proprietary profiling methods that can help you to identify innovative strategies for reversing immune exhaustion and improving the efficacy of cancer immunotherapy.
T cell exhaustion is a sort of dysfunction or 'burnout' condition that often occurs in chronic infections and tumors and is associated with a loss of effector functions, including reduced cytokine secretion, proliferation, and cytotoxicity. A similar 'exhaustion-like' phenotype has been observed in NK cells that reside within the tumor microenvironment (TME). Dissecting these mechanisms is a critical area of research into how to improve immunotherapy, including adoptive transfer approaches, whether CAR-T therapy, TCR-T therapy, or NK cell therapy. Creative Biolabs focuses on addressing the mechanisms underlying both T cell and NK cell exhaustion through its specialized assays, helping researchers design more effective immunotherapies for solid and hematologic malignancies.
T cell exhaustion is a state of functional decline that occurs due to persistent antigen exposure, such as in chronic infections and tumors. Exhausted T cells are characterized by:
Fig.1 T Cell Exhaustion Markers.1,3
Natural killer (NK) cells exhibit exhaustion-like behavior within the tumor microenvironment (TME), characterized by:
Fig.2 NK Cell Exhaustion.2,3
| Technology Description | Common Targets | Examples of Detection | |
|---|---|---|---|
| Flow Cytometry | Multiplex analysis of immune markers to detect exhaustion. | PD-1, TIM-3, LAG-3, TIGIT | Quantifies checkpoint molecules on CAR-T cells. |
| Western Blotting | Simultaneous measurement of cytokines and intracellular proteins. | IFN-γ, IL-2, TNF-α | Detects cytokine expression levels in T cells. |
| Cytokine Profiling | Measures production of multiple cytokines simultaneously. | IL-2, IFN-γ, CCL5 | Reveals immune cell dysfunction. |
| Single-Cell RNA Sequencing | (Recommended) Offers molecular profiling of individual cells. | Exhaustion-related genes: NR4A, BATF3 | Identifies transcriptional signatures of exhausted T/NK cells. |
| Degranulation Assay | Assesses functional cytotoxicity. | Granzyme B, Perforin | Detects effector functions of NK cells. |
In this assay, fresh isolated human PBMCs are stimulated with a fixed concentration of compounds for three days. The media is harvested for hallmark measurements. These assays enable precise measurement of cell dysfunction, helping researchers optimize therapies such as CAR-T cell treatments and checkpoint inhibitors.
Fig.3 Workflow of T/NK Cell Exhaustion Assay.
| Application Description | Use Cases | |
|---|---|---|
| CAR-T Therapy Optimization | Identifies exhaustion markers during CAR-T cell production and persistence. | Enables refinement of CAR-T manufacturing processes. |
| Checkpoint Blockade Evaluation | Assesses effects of inhibitors like PD-1 and CTLA-4 on reversing exhaustion. | Optimizes combination therapies with checkpoint inhibitors. |
| Preclinical Drug Screening | Tests new compounds targeting exhaustion pathways. | Facilitates drug development for enhancing immune therapies. |
| Biomarker Discovery | Identifies exhaustion-related markers predictive of treatment outcomes. | Helps guide personalized therapy decisions. |
Immune cell exhaustion assays from Creative Biolabs are state-of-the-art tools that help to research and unleash the true potential of TCR-T, CAR-T and NK cell therapy. Our assays enable researchers to improve immunotherapy protocols by identifying exhausted immune cells through advanced flow cytometry, cytokine profiling and data interpretation. Besides, Creative Biolabs' solutions have generated significant interest in immune cell research, accompanied by the growing need of effective cancer treatments. We are now working side by side with leading scientists in the field of adoptive cell transfer and breakthrough checkpoint blockade therapies. Our efforts allow us to expand our services to meet the demands of academic researchers as well as the pharmaceutical industry, to ensure that CAR-T and NK cell therapies are as impactful as possible in the clinic. For more details, please feel free to contact us for project quotations and more detailed information.
References